RE:RE:RE:RE:RE:This constant selling........... TLT has identified commercial revenues (projected) starting Jan. 2023. So I assume they have more info and insights than you.
_____________________
LaserStock29 - (5/27/2022 9:25:50 AM)
RE:RE:RE:RE:This constant selling...........
Ya if we apply Q4 2022 for BTD and that takes 6 months.. then AA takes what 4months. Your basically end of 2023 Thanks but no thanks. That won't fly at the agm A buyout of technologies is very much a reasonable position at this point And we know pharma influences fda in decision making aka the vaccine right. So if a big pharma paid roger u know they Seinfeld the hammer to get It the rest of the way I'm absolutely sick of Thomas the blue trail little east york stories of Roger's baby has to grind it out at .30c Endocyte deal is the pinnacle template for a single asset The range for deals is 2-10b. And I didn't say for all of the IP lol